emendrix

Art. 429c

Capital Requirements Regulation · 32013R0575 · every event for this act · on EUR-Lex

Calculation of the exposure value of derivatives

3 changes recorded across 3 events, newest first.

in force 2025-01-01 MODIFIED+847 −192

Amended by Regulation (EU) 2024/1623 32024R1623 · Regulation (EU) 2024/2987 32024R2987 · Regulation (EU) 2024/2795 32024R2795

applies from: unchanged

Point (a) of paragraph 3 now specifies that the received cash must not be segregated from the assets of the institution, whereas the earlier text only said it must not be segregated.

Paragraph 4 was shortened to remove the exception for client derivative contracts cleared by a QCCP, and that exception now appears instead as a new paragraph 4a setting out its own conditions for recognising collateral, including a segregation condition for initial margin.

Paragraph 6 now splits the derogation into point (a), covering derivative contracts listed in Annex II and credit derivatives tied to specific points of Article 92(1), and a new point (b) covering credit derivatives subject to the treatment in Article 273(3) or (5) where the conditions for that method are met, replacing the earlier single reference to contracts listed in points 1 and 2 of Annex II.

Cited: Art. 429c, v2 · Art. 429c, v1

text before / after

02013R0575-2024070902013R0575-20250101

Article 429c Calculation of the exposure value of derivatives 1. Institutions shall calculate the exposure value of derivative contracts listed in Annex II and of credit derivatives, including those that are off-balance-sheet, in accordance with the method set out in Section 3 of Chapter 6 of Title II of Part Three. When calculating the exposure value, institutions may take into account the effects of contracts for novation and other netting agreements in accordance with Article 295. Institutions shall not take into account cross-product netting, but may net within the product category as referred to in point (25)(c) of Article 272 and credit derivatives where they are subject to a contractual cross-product netting agreement as referred to in point (c) of Article 295. Institutions shall include in the total exposure measure sold options even where their exposure value can be set to zero in accordance with the treatment laid down in Article 274(5). 2. Where the provision of collateral related to derivative contracts reduces the amount of assets under the applicable accounting framework, institutions shall reverse that reduction. 3. For the purposes of paragraph 1 of this Article, institutions calculating the replacement cost of derivative contracts in accordance with Article 275 may recognise only collateral received in cash from their counterparties as the variation margin referred to in Article 275, where the applicable accounting framework has not already recognised the variation margin as a reduction of the exposure value and where all the following conditions are met: (a) for trades not cleared through a QCCP, the cash received by the recipient counterparty is not segregated; segregated from the assets of the institution; (b) the variation margin is calculated and exchanged at least daily based on a mark-to-market valuation of derivatives positions; (c) the variation margin received is in a currency specified in the derivative contract, governing master netting agreement, credit support annex to the qualifying master netting agreement or as defined by any netting agreement with a QCCP; (d) the variation margin received is the full amount that would be necessary to extinguish the mark-to-market exposure of the derivative contract subject to the threshold and minimum transfer amounts that are applicable to the counterparty; (e) the derivative contract and the variation margin between the institution and the counterparty to that contract are covered by a single netting agreement that the institution may treat as risk-reducing in accordance with Article 295. Where an institution provides cash collateral to a counterparty and that collateral meets the conditions set out in points (a) to (e) of the first subparagraph, the institution shall consider that collateral as the variation margin posted with the counterparty and shall include it in the calculation of the replacement cost. For the purposes of point (b) of the first subparagraph, an institution shall be considered to have met the condition set out therein where the variation margin is exchanged on the morning of the trading day following the trading day on which the derivative contract was stipulated, provided that the exchange is based on the value of the contract at the end of the trading day on which the contract was stipulated. For the purposes of point (d) of the first subparagraph, where a margin dispute arises, institutions may recognise the amount of non-disputed collateral that has been exchanged. 4. For the purposes of paragraph 1 of this Article, institutions shall not include collateral received in the calculation of NICA as defined in point (12a) of Article 272, except point (12a). 4a. By way of derogation from paragraphs 3 and 4, an institution may recognise any collateral received in accordance with Part Three, Title II, Chapter 6, Section 3 where all of the following conditions are met: (a) the collateral is received from a client for a derivative contract cleared by the institution on behalf of that client; (b) the contract referred to in point (a) is cleared through a QCCP; (c) where the collateral has been received in the case form of derivative contracts with clients where those contracts are cleared by a QCCP. initial margin, that collateral is segregated from the assets of the institution. 5. For the purposes of paragraph 1 of this Article, institutions shall set the value of the multiplier used in the calculation of the potential future exposure in accordance with Article 278(1) to one, except in the case of derivative contracts with clients where those contracts are cleared by a QCCP. 6. By way of derogation from paragraph 1 of this Article, institutions may use the method set out in Part Three, Title II, Chapter 6, Section 4 or 5 of Chapter 6 of Title II of Part Three to determine the exposure value of the following: (a) derivative contracts listed in points 1 Annex II and 2 of Annex II, but only credit derivatives, where they also use that method for determining the exposure value of those contracts for the purpose purposes of meeting the own funds requirements set out in Article 92. 92(1), points (a), (b) and (c); (b) credit derivatives to which they apply the treatment set out in Article 273(3) or (5), where the conditions to use that method are met. Where institutions apply one of the methods referred to in the first subparagraph, they shall not reduce the total exposure measure by the amount of margin they have received.

in force 2024-07-09 MODIFIED

Amended by Regulation (EU) 2024/1623 32024R1623

applies from: unknown

Sources disagree — the amending act's instructions found this change; the text comparison finds no difference in the provision's text and the EU's own amendment metadata does not list it. All are shown; none is overruled.

No explanation shipped — the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships as `disputed`.

text before / after, on the event page →

in force 2021-06-28 INSERTED

Amended by Regulation (EU) 2019/2033 32019R2033 · Regulation (EU) 2019/876 32019R0876 · Regulation (EU) 2021/558 32021R0558 · Regulation (EU) 2020/873 32020R0873

applies from: unknown (an inserted provision states its own application date only in prose)

Sources disagree — the text comparison found this change; the EU's own amendment metadata does not list it. Both are shown; neither is overruled.

This is a new provision setting out how institutions calculate the exposure value of derivative contracts and credit derivatives for the leverage ratio, including rules on netting, collateral, variation margin, NICA, and the potential future exposure multiplier.

It also allows institutions to use an alternative method under Section 4 or 5 of Chapter 6 of Title II of Part Three for certain listed derivative contracts, subject to using that same method for own funds requirement purposes, and specifies that margin received may not then reduce the total exposure measure.

Cited: Art. 429c, v2

text before / after, on the event page →